Twin Tree Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
– Sell
-16,974
Closed -$2.56M – 1678
2021
Q2
$3.02M Buy
16,974
+7,721
+83% +$1.34M 0.01% 798
2021
Q1
$1.52M Buy
9,253
+3,231
+54% +$532K 0.01% 908
2020
Q4
$994K Sell
6,022
-7,646
-56% -$1.14M ﹤0.01% 972
2020
Q3
$1.95M Buy
13,668
+7,744
+131% +$960K 0.01% 772
2020
Q2
$654K Buy
5,924
+1,752
+42% +$194K ﹤0.01% 1116
2020
Q1
$416K Sell
4,172
-8,376
-67% -$1.08M ﹤0.01% 994
2019
Q4
$1.87M Buy
12,548
+3,751
+43% +$510K 0.01% 741
2019
Q3
$1.13M Buy
8,797
+4,483
+104% +$601K ﹤0.01% 807
2019
Q2
$615K Sell
4,314
-11,678
-73% -$1.57M ﹤0.01% 872
2019
Q1
$2.29M Buy
15,992
+14,106
+748% +$1.84M 0.01% 645
2018
Q4
$234K Buy
+1,886
New +$280K ﹤0.01% 1048
2018
Q2
– Sell
-112
Closed -$17K – 1249
2018
Q1
$17K Buy
+112
New +$16.4K ﹤0.01% 1038
2017
Q3
– Sell
-1,536
Closed -$239K – 1067
2017
Q2
$239K Sell
1,536
-2,532
-62% -$387K ﹤0.01% 804
2017
Q1
$590K Buy
+4,068
New +$530K 0.01% 758
2016
Q4
– Sell
-9,314
Closed -$1.13M – 1260
2016
Q3
$1.13M Buy
+9,314
New +$1.26M 0.01% 634
2015
Q4
– Sell
-795
Closed -$110K – 1479
2015
Q3
$106K Sell
795
-453
-36% -$78K ﹤0.01% 1098
2015
Q2
$220K Buy
1,248
+185
+17% +$33.2K 0.01% 1050
2015
Q1
$184K Sell
1,063
-388
-27% -$66.6K ﹤0.01% 966
2014
Q4
$238K Buy
+1,451
New +$241K 0.01% 886

Other funds holding JAZZ

Twin Tree Management's JAZZ Position: Q3 2021 in Review

Twin Tree Management sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2021, closing a stake of 16,974 shares — an estimated $2.56M sold.

Twin Tree Management first reported a position in JAZZ in Q4 2014 and held it in 19 quarters. The position peaked at $3.02M in Q2 2021. 455 funds tracked by Wall St. Rank hold JAZZ as of Q3 2021.

  • Twin Tree Management reported no remaining Jazz Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Twin Tree Management sold 16,974 Jazz Pharmaceuticals shares in Q3 2021, an estimated $2.56M.
  • Twin Tree Management first reported a position in Jazz Pharmaceuticals in Q4 2014 and held it in 19 quarters.
  • Twin Tree Management's Jazz Pharmaceuticals position peaked at $3.02M in Q2 2021.
  • 455 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2021.

Based on Twin Tree Management's 13F filing for Q3 2021, filed 12 Nov 2021.